Recombinant Anti-DTPA x Anti-GD2 Bispecific Antibody (Tandem scFv-Fc) (BSFVF-153)

Recombinant Anti-DTPA x Anti-GD2 Bispecific Antibody (Tandem scFv-Fc) is designed to be expressed as a homodimer, which has 2+2 antigen-binding valency. This format consists of one Fc region and two tandem scFv fragments, in which the anti-DTPA/GD2 tandem scFv is fused to the Fc domain. The engineered fragment format is used to extend the half-life. This BsAb can be used in pretargeting system of PET, radioimaging or radiotherapy. It can mediate targeting of radioactivity to tumor cells. It is designed for the research of Neuroblastoma; Osteosarcoma; Melanoma; Solid tumors imaging and therapy.

Datasheet INQUIRY

Specifications

Targets

DTPA & GD2

Type

Constant Domain-extended Bispecific Fragments

Species Reactivity

Human

Application

FuncS; Pretargeting system for radioimaging and radiotherapy

Related Disease

Neuroblastoma; Osteosarcoma; Melanoma; Solid tumors

Targets

Target 1

DTPA

Alternative Names

diethylenetriaminepentaacetic acid; DTPA; pentetic acid

Target 2

GD2

Alternative Names

Ganglioside GD2; GD2; Ganglioside; Disialoganglioside GD2

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-DTPA x Anti-GD2 Bispecific Antibody (Tandem scFv-Fc) (BSFVF-153). Click the button below to contact us or submit your feedback about this product.

Recombinant Anti-DTPA x Anti-GD2 Bispecific Antibody (Tandem scFv-Fc) (CAT#: BSFVF-153)

Specifications

Targets

Customer Reviews and Q&As